TMEM127 suppresses tumor development by promoting RET ubiquitination, positioning, and degradation-Reference-Cited by-同舟云学术

TMEM127 suppresses tumor development by promoting RET ubiquitination, positioning, and degradation

Published:2023-09 Issue:9 Volume:42 Page:113070
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Guo Qianjin,Cheng Zi-Ming,Gonzalez-Cantú Hector,Rotondi Matthew,Huelgas-Morales Gabriela,Ethiraj Purushoth,Qiu Zhijun,Lefkowitz Jonathan,Song Wan,Landry Bethany N.,Lopez Hector,Estrada-Zuniga Cynthia M.,Goyal Shivi,Khan Mohammad Aasif,Walker Timothy J.,Wang Exing,Li Faqian,Ding Yanli,Mulligan Lois M.,Aguiar Ricardo C.T.,Dahia Patricia L.M.^ORCID

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference85 articles.

1. Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity;Dahia;Nat. Rev. Cancer,2014

2. Germline mutations in TMEM127 confer susceptibility to pheochromocytoma;Qin;Nat. Genet.,2010

3. Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma;Fishbein;Cancer Cell,2017

4. A HIF1alpha regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas;Dahia;PLoS Genet.,2005

5. Functional Characterization of TMEM127 Variants Reveals Novel Insights into Its Membrane Topology and Trafficking;Flores;J. Clin. Endocrinol. Metab.,2020

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metastatic pheochromocytoma and paraganglioma: Integrating tumor biology in clinical practice;Molecular and Cellular Endocrinology;2024-10

2. Mapping the cancer surface proteome in search of target antigens for immunotherapy;Molecular Therapy;2024-09

3. Recent progress in molecular classification of phaeochromocytoma and paraganglioma;Best Practice & Research Clinical Endocrinology & Metabolism;2024-09

4. Genetic and Molecular Biomarkers in Aggressive Pheochromocytomas and Paragangliomas;International Journal of Molecular Sciences;2024-06-28

5. Loss of tumor suppressor TMEM127 drives RET-mediated transformation through disrupted membrane dynamics;ELIFE;2024